OptimizeRx (OPRX) Shares Outstanding (2010 - 2026)

OptimizeRx has reported Shares Outstanding (Entity) for 17 years, with the latest figure at $20.5 million in Q1 2026.

• Quarterly Shares Outstanding (Entity) rose 1.35% year-over-year to $20.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $20.5 million (up 1.35% YoY) and the FY2025 annual result came in at $20.5 million, up 1.52% from the prior year.
• Shares Outstanding (Entity) steadied at $20.5 million in Q1 2026 per OPRX's latest filing, from $20.5 million in the prior quarter.
• Over five years, Shares Outstanding (Entity) peaked at $20.5 million in Q1 2026 and troughed at $17.9 million in Q1 2022.
• A 5-year average of $19.4 million and a median of $19.9 million in 2024 frame the typical range for Shares Outstanding (Entity).
• The sharpest annual moves came in 2023 and 2024: Shares Outstanding (Entity) increased 0.69% in 2023, then gained 9.17% in 2024.
• Over 5 years, Shares Outstanding (Entity) stood at $18.3 million in 2022, then grew by 8.81% to $19.9 million in 2023, then rose by 1.48% to $20.2 million in 2024, then grew by 1.52% to $20.5 million in 2025, then rose by 0.03% to $20.5 million in 2026.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $20.5 million, $20.5 million, and $20.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.